Glenmark Life Sciences IPO opens today on July 27.

Chittorgarh

IPO Investment Portal
#1
Incorporated in 2011, Glenmark Life Sciences is the leading manufacturer of Active Pharmaceutical Ingredients (APIs). The company develops, manufactures, and supplies high-quality APIs for cardiovascular disease (CVS), central nervous system disease (CNS), pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas.
Glenmark Life Sciences IPO Issue Details;
• Issue Type: Book Built Issue IPO
• Issue Date: July 27 2021 - July 29, 2021
• Issue Size: ₹1,513.60 Cr
• Issue Price: ₹695-720 Per Equity Share
• Face Value: ₹2 Per Equity Shares
• Market Lot: 20 Shares
• Listing At: BSE, NSE
For more details, please visit the Glenmark Life Sciences IPO Issue Details page.
 

Similar threads